JANX
Janux Therapeutics Inc
17.90$
+6.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 506.6% | 982.8% | 725.3% | 691.2% | 640.9% | 595.6% | 757.7% | 542.5% | 774.7% | 1,411.9% | 19.9% | 21.6% | 42.5% | 5.7% | 540.8% | – | – | – | 5.0% | 113.5% | 12.6% | – | – | |
| – | – | – | – | -406.6% | -882.8% | -625.3% | -591.2% | -540.9% | -495.6% | -657.7% | -442.5% | -674.7% | -1,311.9% | 80.1% | 78.4% | 57.5% | 94.3% | -440.8% | – | – | – | 95.0% | -13.5% | 87.4% | 100.0% | 68.9% | |
| – | – | – | – | 506.6% | 982.8% | 725.3% | 691.2% | 640.9% | 595.6% | 757.7% | 542.5% | 774.7% | 1,411.9% | 472.5% | 497.4% | 1,123.8% | 167.4% | 4,240.1% | – | – | – | 346.3% | 400.4% | 718.3% | 301.9% | 388.9% | |
| – | – | – | – | 194.5% | 414.3% | 315.4% | 243.6% | 311.3% | 234.2% | 336.3% | 199.5% | 315.6% | 651.0% | 255.8% | 258.3% | 586.5% | 87.9% | 4,024.4% | – | – | – | 106.2% | 137.7% | 298.2% | 106.8% | 136.7% | |
| – | – | – | – | 194.5% | 414.3% | 315.4% | 243.6% | 311.3% | 234.2% | 336.3% | 199.5% | 315.6% | 651.0% | 708.4% | 734.1% | 1,667.8% | 249.7% | 7,723.7% | – | – | – | 447.5% | 524.6% | 1,003.9% | 408.7% | 519.2% | |
| – | – | – | – | -601.1% | -1,297.1% | -940.7% | -834.8% | -852.2% | -729.9% | -994.0% | -642.0% | -990.3% | -1,962.9% | -628.2% | -655.7% | -1,610.3% | -155.4% | -8,164.5% | – | – | – | -352.5% | -538.1% | -916.5% | -308.7% | -450.3% | |
| – | – | – | – | 0.0% | 9.5% | 11.8% | 4.6% | 8.3% | 15.8% | 73.1% | 77.4% | 159.9% | – | – | 133.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -601.1% | -1,287.6% | -928.9% | -830.2% | -843.9% | -714.1% | -920.9% | -564.7% | -852.5% | -1,656.4% | -459.6% | -477.8% | -1,178.9% | -67.0% | -6,391.6% | – | – | – | -243.1% | -405.4% | -652.6% | -214.0% | -321.8% | |
| – | – | – | – | – | 9.5% | 11.8% | -4.6% | -16.6% | -15.8% | -146.3% | -168.9% | -22.1% | 33.0% | -19.9% | 38.7% | 39.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -601.1% | -1,287.6% | -928.9% | -830.2% | -843.9% | -714.1% | -920.9% | -564.7% | -852.5% | -1,656.4% | -459.6% | -477.8% | -1,178.9% | -67.0% | -6,391.6% | – | – | – | -243.1% | -405.4% | -652.6% | -214.0% | -321.8% | |
| – | – | – | – | -598.7% | -1,284.9% | -926.6% | -826.2% | -838.8% | -709.5% | -907.2% | -550.5% | -830.4% | -1,611.8% | -439.7% | -456.2% | -1,136.4% | -61.3% | -6,275.4% | – | – | – | -238.1% | -398.8% | -640.0% | -214.0% | -317.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.